Prestige BioPharma Limited (950210.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

KRW 388.82B

MomentumView details →

1D Return

−3.72%

YTD Return

−49.42%

RSI (14)

53.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

KRW 388.82B

RSI (14)

53.5

MomentumView details →

1D Return

−3.72%

YTD Return

−49.42%

ProfitabilityView details →

Gross Margin

−86.10%

Net Margin

−383.26%

EBITDA Margin

−273.34%

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

+77.75%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+435.29%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

25.23B

Net Income (TTM)

−96.68B

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 950210.KS.

Similar companies

AbClon Inc.174900.KQ NeoImmuneTech, Inc.950220.KQ 百济神州688235.SH MEDIPOST Co., Ltd.078160.KQ Green Cross Holdings Corporation005250.KS Proteina Co., Ltd.468530.KQ Find similar companies →

Latest newsMore news →

No recent news for 950210.KS.